| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Germ Cell and Embryonal | 5 | 2022 | 12 | 1.040 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2022 | 17 | 0.770 |
Why?
|
| Cisplatin | 6 | 2023 | 20 | 0.600 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 77 | 0.580 |
Why?
|
| Arabidopsis | 3 | 2023 | 97 | 0.580 |
Why?
|
| Myocardial Infarction | 3 | 2022 | 28 | 0.560 |
Why?
|
| Animals | 15 | 2023 | 1545 | 0.550 |
Why?
|
| Humans | 19 | 2023 | 4119 | 0.540 |
Why?
|
| Histone Deacetylases | 3 | 2022 | 11 | 0.450 |
Why?
|
| Transcriptome | 4 | 2022 | 201 | 0.440 |
Why?
|
| Liver Regeneration | 2 | 2023 | 9 | 0.440 |
Why?
|
| Remyelination | 2 | 2022 | 5 | 0.420 |
Why?
|
| Testicular Neoplasms | 2 | 2022 | 6 | 0.420 |
Why?
|
| Cell Line, Tumor | 8 | 2023 | 161 | 0.400 |
Why?
|
| Neural Stem Cells | 2 | 2022 | 24 | 0.400 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 102 | 0.390 |
Why?
|
| Mice | 9 | 2023 | 737 | 0.390 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 11 | 0.390 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 98 | 0.370 |
Why?
|
| Dendritic Cells | 2 | 2021 | 81 | 0.370 |
Why?
|
| Signal Transduction | 5 | 2023 | 261 | 0.370 |
Why?
|
| Hepatectomy | 2 | 2023 | 5 | 0.280 |
Why?
|
| Azetidines | 2 | 2022 | 4 | 0.280 |
Why?
|
| Neutrophils | 2 | 2022 | 33 | 0.270 |
Why?
|
| Cell Proliferation | 3 | 2022 | 129 | 0.270 |
Why?
|
| Transcription Factors | 3 | 2023 | 256 | 0.270 |
Why?
|
| Pipecolic Acids | 2 | 2023 | 4 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 111 | 0.260 |
Why?
|
| Chromatin | 2 | 2022 | 49 | 0.250 |
Why?
|
| Regulon | 1 | 2023 | 4 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 12 | 0.230 |
Why?
|
| Interleukin-11 | 1 | 2023 | 4 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 226 | 0.230 |
Why?
|
| RNA Stability | 1 | 2023 | 36 | 0.230 |
Why?
|
| Up-Regulation | 2 | 2020 | 62 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 8 | 0.230 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 30 | 0.230 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 29 | 0.230 |
Why?
|
| Urologic Neoplasms | 1 | 2022 | 2 | 0.220 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 14 | 0.220 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 13 | 0.220 |
Why?
|
| Heart Failure | 1 | 2022 | 16 | 0.220 |
Why?
|
| Adverse Outcome Pathways | 1 | 2022 | 2 | 0.220 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2022 | 3 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 4 | 0.220 |
Why?
|
| Male | 6 | 2022 | 1811 | 0.220 |
Why?
|
| Hyaluronan Receptors | 1 | 2021 | 2 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 2 | 0.210 |
Why?
|
| Carcinoma, Embryonal | 1 | 2021 | 3 | 0.210 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 7 | 0.210 |
Why?
|
| Plant Immunity | 1 | 2021 | 4 | 0.200 |
Why?
|
| Host-Parasite Interactions | 1 | 2021 | 2 | 0.200 |
Why?
|
| Toxoplasma | 1 | 2021 | 2 | 0.200 |
Why?
|
| Toxoplasmosis | 1 | 2021 | 2 | 0.200 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2021 | 5 | 0.200 |
Why?
|
| Plant Diseases | 1 | 2021 | 23 | 0.200 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 23 | 0.200 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 33 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 50 | 0.200 |
Why?
|
| Polybrominated Biphenyls | 1 | 2020 | 2 | 0.190 |
Why?
|
| Flame Retardants | 1 | 2020 | 3 | 0.190 |
Why?
|
| Aminopyridines | 1 | 2020 | 3 | 0.190 |
Why?
|
| Purines | 1 | 2020 | 4 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2020 | 4 | 0.190 |
Why?
|
| Piperazines | 1 | 2020 | 7 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2020 | 5 | 0.190 |
Why?
|
| Pyridines | 1 | 2020 | 6 | 0.190 |
Why?
|
| Pericardium | 1 | 2020 | 6 | 0.190 |
Why?
|
| Stromal Cells | 1 | 2020 | 13 | 0.190 |
Why?
|
| Interleukin-10 | 1 | 2020 | 12 | 0.190 |
Why?
|
| Flaveria | 1 | 2020 | 1 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2021 | 99 | 0.190 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 19 | 0.190 |
Why?
|
| Myocardium | 1 | 2020 | 28 | 0.190 |
Why?
|
| Cell Separation | 1 | 2020 | 30 | 0.180 |
Why?
|
| Fibroblasts | 1 | 2020 | 71 | 0.180 |
Why?
|
| Skin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Repressor Proteins | 1 | 2020 | 48 | 0.180 |
Why?
|
| Fatty Acids | 2 | 2022 | 25 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 43 | 0.180 |
Why?
|
| Urothelium | 1 | 2019 | 2 | 0.180 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Carcinoma | 1 | 2019 | 10 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 7 | 0.170 |
Why?
|
| Organogenesis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 26 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 18 | 0.170 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sweat Glands | 1 | 2019 | 3 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 4 | 0.170 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2019 | 6 | 0.170 |
Why?
|
| Retina | 1 | 2019 | 26 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2018 | 31 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 74 | 0.170 |
Why?
|
| Female | 5 | 2021 | 2147 | 0.160 |
Why?
|
| Microglia | 3 | 2022 | 35 | 0.160 |
Why?
|
| Cell Survival | 3 | 2022 | 45 | 0.150 |
Why?
|
| Rats | 3 | 2022 | 164 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2020 | 261 | 0.130 |
Why?
|
| Yarrowia | 1 | 2014 | 1 | 0.130 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2014 | 6 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 58 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 944 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2023 | 15 | 0.110 |
Why?
|
| Benzyl Compounds | 2 | 2022 | 4 | 0.110 |
Why?
|
| Hepatocytes | 2 | 2023 | 12 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 19 | 0.110 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2023 | 86 | 0.100 |
Why?
|
| Macrophages | 2 | 2023 | 124 | 0.100 |
Why?
|
| Inflammation | 2 | 2022 | 179 | 0.100 |
Why?
|
| Plant Leaves | 2 | 2021 | 36 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 143 | 0.090 |
Why?
|
| Genotype | 2 | 2021 | 320 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2023 | 263 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2021 | 149 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 345 | 0.080 |
Why?
|
| Mutation | 2 | 2020 | 608 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 22 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2023 | 2 | 0.060 |
Why?
|
| Receptors, Interleukin-11 | 1 | 2023 | 3 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2023 | 8 | 0.060 |
Why?
|
| Bortezomib | 1 | 2023 | 3 | 0.060 |
Why?
|
| Salicylic Acid | 1 | 2023 | 5 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2023 | 43 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2023 | 48 | 0.060 |
Why?
|
| Gene Expression | 1 | 2023 | 138 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2022 | 5 | 0.060 |
Why?
|
| Lipase | 1 | 2022 | 8 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2022 | 8 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 8 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2022 | 7 | 0.060 |
Why?
|
| Fibronectins | 1 | 2022 | 5 | 0.060 |
Why?
|
| Lipids | 1 | 2022 | 26 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 11 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 22 | 0.050 |
Why?
|
| Insulins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 10 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 18 | 0.050 |
Why?
|
| Laminin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2022 | 26 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2022 | 47 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2022 | 40 | 0.050 |
Why?
|
| Cuprizone | 1 | 2022 | 4 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2022 | 50 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 13 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 9 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 24 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2021 | 9 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 77 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 2 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2021 | 5 | 0.050 |
Why?
|
| CD24 Antigen | 1 | 2021 | 5 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2021 | 12 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 39 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2021 | 115 | 0.050 |
Why?
|
| Pseudomonas syringae | 1 | 2021 | 4 | 0.050 |
Why?
|
| Cell Line | 1 | 2022 | 137 | 0.050 |
Why?
|
| Lymphotoxin-beta | 1 | 2021 | 2 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Apoptosis | 1 | 2021 | 94 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2021 | 23 | 0.050 |
Why?
|
| Genes, Plant | 1 | 2021 | 55 | 0.050 |
Why?
|
| Young Adult | 1 | 2022 | 345 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 4 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2020 | 8 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 13 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2021 | 58 | 0.050 |
Why?
|
| Biomarkers | 1 | 2021 | 188 | 0.050 |
Why?
|
| Adolescent | 1 | 2022 | 493 | 0.050 |
Why?
|
| Isolated Heart Preparation | 1 | 2020 | 2 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 173 | 0.050 |
Why?
|
| Action Potentials | 1 | 2020 | 9 | 0.050 |
Why?
|
| Demethylation | 1 | 2020 | 1 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2021 | 189 | 0.050 |
Why?
|
| Photosynthesis | 1 | 2020 | 15 | 0.050 |
Why?
|
| Time Factors | 1 | 2020 | 115 | 0.050 |
Why?
|
| Copper-transporting ATPases | 1 | 2019 | 2 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 3 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2019 | 4 | 0.050 |
Why?
|
| Karyotype | 1 | 2019 | 11 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 90 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 24 | 0.050 |
Why?
|
| Neurons | 1 | 2020 | 78 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 44 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 64 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 37 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Fingers | 1 | 2019 | 13 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 111 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2020 | 199 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Echocardiography | 1 | 2018 | 14 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 39 | 0.040 |
Why?
|
| Child | 1 | 2020 | 557 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 206 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 71 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 479 | 0.040 |
Why?
|
| Aged | 1 | 2019 | 580 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 843 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 30 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 57 | 0.030 |
Why?
|
